Acute Pancreatitis Clinical Practice Guideline

1. Introduction

Acute pancreatitis (AP) is an abrupt inflammation of the pancreas that can range from a mild, selflimiting episode to a severe, lifethreatening condition with multiorgan failure. Early identification, risk stratification, and evidencebased management are essential to improve outcomes. This guideline summarizes current recommendations for the diagnosis, initial assessment, and therapeutic strategies for adult patients with acute pancreatitis.

2. Diagnosis

2.1 Clinical Presentation

Typical symptoms include sudden onset epigastric pain radiating to the back, nausea, and vomiting. The pain is frequently described as constant, severe, and worsened by lying supine.

2.2 Diagnostic Criteria

A diagnosis of acute pancreatitis is made when at least two of the following three criteria are present:

1. Abdominal pain characteristic of pancreatitis.
2. Serum amylase and/or lipase level 3 times the upper limit of normal.
3. Imaging findings (contrastenhanced CT, MRI, or transabdominal ultrasound) consistent with pancreatitis.

2.3 Role of Imaging

Transabdominal ultrasound is the firstline imaging modality to evaluate for gallstones, biliary obstruction, and to rule out other intraabdominal pathology. Contrastenhanced computed tomography (CECT) is reserved for patients with uncertain diagnosis, suspected necrosis, or worsening clinical course after 4872hours.

3. Initial Management

3.1 Fluid Resuscitation

Early aggressive intravenous fluid therapy is the cornerstone of treatment.

• Start with a crystalloid bolus of 1520mL/kg (e.g., lactated Ringers solution) within the first hour.
• Target urine output0.5mL/kg/h, hematocrit 3544% (or a decreasing trend), and a mean arterial pressure65mmHg.
• Adjust rates based on hemodynamic response, cardiac function, and renal status; typically 2.54mL/kg/h after the initial bolus.

3.2 Analgesia

Effective pain control improves patient comfort and respiratory mechanics.

• Use a stepwise approach: nonopioid analgesics (acetaminophen or NSAIDs) first, escalating to opioids (e.g., morphine, hydromorphone) as needed.
• Avoid excessive sedation that may impair cough and deepbreathing.

3.3 Nutritional Support

Early enteral nutrition is recommended for most patients.

• Oral feeding can be initiated as soon as the patient tolerates liquids without nausea or vomiting.
• If oral intake is not possible within 2448hours, start a nasojejunal or nasogastric tube for lowfat, lowfiber enteral feeding.
• Parenteral nutrition is reserved for patients with contraindications to enteral feeding or persistent intolerance after 57days.

4. Etiology Assessment

Identifying the underlying cause guides specific therapy.

• Biliary obstruction confirmed by ultrasound or MRCP; treat with early endoscopic retrograde cholangiopancreatography (ERCP) in cases of cholangitis or persistent obstruction.
• Alcohol counsel on cessation; consider referral to addiction services.
• Hypertriglyceridemia triglycerides >1000mg/dL; treat with insulin infusion, apheresis, or fibrates.
• Druginduced discontinue offending agents.
• Idiopathic consider further imaging (EUS, MRCP) if initial workup is unrevealing.

5. Severity Stratification

Accurate early risk stratification predicts complications and guides level of care.

5.1 Clinical Scoring Systems

• Ransons Criteria assessed at admission and 48hours; >3 points suggests severe disease.
• APACHEII score 8 within the first 24hours predicts increased mortality.
• BISAP bedside score (BUN >25mg/dL, Impaired mental status, SIRS, Age >60y, Pleural effusion); 2 points indicates higher risk.

5.2 ImagingBased Assessment

Contrastenhanced CT performed after 4872hours can identify pancreatic necrosis and local complications. The revised Atlanta classification categorizes AP as:

• Mild no organ failure, no local/systemic complications.
• Moderately severe transient organ failure (<48h) or local complications.
• Severe persistent organ failure (>48h), possibly combined with necrosis.

6. Management of Complications

6.1 Organ Failure

Supportive care in an intensive care unit is required for persistent respiratory, cardiovascular, or renal failure.

• Ventilatory support with low tidal volumes.
• Vasopressors for refractory hypotension.
• Renal replacement therapy when indicated.

6.2 Necrotizing Pancreatitis

Approach is stepup, minimally invasive whenever possible.

1. Conservative management for sterile necrosis observation, antibiotics only if infection is proven.
2. If infected necrosis is suspected (fever, leukocytosis, gas on CT), obtain fineneedle aspiration for culture.
3. Initiate broadspectrum antibiotics (e.g., carbapenem or piperacillintazobactam) pending culture results.
4. Drainage options: percutaneous catheter drainage, endoscopic transluminal drainage, or minimally invasive retroperitoneal surgery.

6.3 Pseudocyst and WalledOff Necrosis

Intervention is indicated for symptomatic lesions, infection, or complications (bleeding, obstruction).

• Endoscopic ultrasoundguided drainage is firstline.
• Surgical or radiologic drainage is reserved for failed endoscopic therapy.

7. Antibiotic Use

Routine prophylactic antibiotics are not recommended for sterile pancreatitis.

• Administer antibiotics only when there is documented or highly suspected infection.
• Choose agents with good pancreatic tissue penetration; duration typically 710days or until clinical resolution.

8. Role of Endoscopy

Early ERCP is indicated for patients with concurrent cholangitis, biliary obstruction, or gallstone pancreatitis with ongoing jaundice.

Endoscopic sphincterotomy reduces the risk of recurrent biliary pancreatitis and should be performed during the same admission when feasible.

9. Discharge Planning and Followup

Patients can be discharged once pain is controlled, oral intake is adequate, and no organ failure or infection persists.

• Educate regarding avoidance of alcohol and triglycerideraising foods.
• Arrange followup imaging (usually ultrasound or MRI) at 46weeks to assess for residual fluid collections.
• Referral to gastroenterology or surgery for evaluation of cholecystectomy in gallstonerelated cases (ideally within 6weeks of discharge).

10. Summary of Key Recommendations

• Confirm diagnosis with two of three criteria: characteristic pain, >3 ULN amylase/lipase, imaging.
• Initiate aggressive crystalloid resuscitation early; target urine output and hemodynamics.
• Provide adequate analgesia and start early enteral nutrition.
• Identify etiology promptly; perform early ERCP for biliary obstruction with cholangitis.
• Use validated scoring systems (BISAP, APACHEII) for early severity assessment.
• Reserve antibiotics for proven or highly suspected infection; avoid prophylaxis.
• Adopt a stepup approach for necrotizing pancreatitis and infected collections.
• Plan cholecystectomy for gallstone pancreatitis before discharge or within 6weeks.

11. References

1. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis2012: Revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102111.

2. Working Group IAP/APA. IAP/APA evidencebased guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4 Suppl 2):e1e15.

3. Forsmark CE, Baillie J, Vujkovac L, et al. Automated early identification of severe acute pancreatitis using bedside scoring systems. Clin Gastroenterol Hepatol. 2020;18(5):945951.

4. van Santvoort HC, Bollen TL, Besselink MG, et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. N Engl J Med. 2010;362(5):417430.

5. Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):14001415.